Willem Scholten

1.4k total citations
45 papers, 942 citations indexed

About

Willem Scholten is a scholar working on Public Health, Environmental and Occupational Health, Anesthesiology and Pain Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Willem Scholten has authored 45 papers receiving a total of 942 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Public Health, Environmental and Occupational Health, 19 papers in Anesthesiology and Pain Medicine and 14 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Willem Scholten's work include Opioid Use Disorder Treatment (23 papers), Pain Management and Opioid Use (19 papers) and Pediatric Pain Management Techniques (9 papers). Willem Scholten is often cited by papers focused on Opioid Use Disorder Treatment (23 papers), Pain Management and Opioid Use (19 papers) and Pediatric Pain Management Techniques (9 papers). Willem Scholten collaborates with scholars based in Germany, Netherlands and Switzerland. Willem Scholten's co-authors include Lukas Radbruch, Barbara Milani, James F. Cleary, Nathan I. Cherny, Julie Torode, Jack E. Henningfield, Sheila Payne, Nicola Magrini, Andy Gray and Phil Wiffen and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Public Health and The Lancet Oncology.

In The Last Decade

Willem Scholten

45 papers receiving 890 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Willem Scholten Germany 16 590 457 349 97 95 45 942
M. R. Rajagopal India 16 418 0.7× 229 0.5× 237 0.7× 90 0.9× 54 0.6× 50 698
Martha A. Maurer United States 13 329 0.6× 232 0.5× 150 0.4× 39 0.4× 39 0.4× 45 505
Roger Hunt Australia 13 621 1.1× 97 0.2× 230 0.7× 67 0.7× 51 0.5× 29 1.0k
Diederik Lohman United States 9 206 0.3× 136 0.3× 162 0.5× 46 0.5× 38 0.4× 19 412
Andrew W. Roberts United States 15 353 0.6× 190 0.4× 140 0.4× 49 0.5× 61 0.6× 33 577
Ariadne Rivera‐Aguirre United States 16 642 1.1× 127 0.3× 235 0.7× 23 0.2× 86 0.9× 28 968
Elizabeth Magnan United States 13 311 0.5× 185 0.4× 57 0.2× 38 0.4× 63 0.7× 29 570
Andrew Dickman United Kingdom 12 241 0.4× 451 1.0× 394 1.1× 165 1.7× 17 0.2× 29 762
Virginia LeBaron United States 15 301 0.5× 93 0.2× 135 0.4× 20 0.2× 30 0.3× 62 604
Donald Bourne United States 14 251 0.4× 73 0.2× 61 0.2× 31 0.3× 43 0.5× 30 509

Countries citing papers authored by Willem Scholten

Since Specialization
Citations

This map shows the geographic impact of Willem Scholten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Willem Scholten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Willem Scholten more than expected).

Fields of papers citing papers by Willem Scholten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Willem Scholten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Willem Scholten. The network helps show where Willem Scholten may publish in the future.

Co-authorship network of co-authors of Willem Scholten

This figure shows the co-authorship network connecting the top 25 collaborators of Willem Scholten. A scholar is included among the top collaborators of Willem Scholten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Willem Scholten. Willem Scholten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amsterdam, Jan van, Gjalt-Jorn Peters, E. J. M. Pennings, et al.. (2021). Developing a new national MDMA policy: Results of a multi-decision multi-criterion decision analysis. Journal of Psychopharmacology. 35(5). 537–546. 3 indexed citations
2.
Dickson, Cheryl, et al.. (2021). Agonist Treatment for Opioid Dependence Syndrome: The Impact of Current Understanding upon Recommendations for Policy Initiatives. International Journal of Environmental Research and Public Health. 18(19). 10155–10155. 1 indexed citations
3.
Scholten, Willem, et al.. (2020). Epidural anesthesia is no longer the standard of care in abdominal surgery with ERAS. What are the alternatives?. Minerva Anestesiologica. 86(10). 1079–1088. 15 indexed citations
4.
Scholten, Willem, et al.. (2019). Analyzing and Benchmarking Global Consumption Statistics for Opioid Analgesics 2015: Inequality Continues to Increase. Journal of Pain & Palliative Care Pharmacotherapy. 34(1). 1–12. 11 indexed citations
5.
Mantel‐Teeuwisse, Aukje K., Lukas Radbruch, Marie-Hélène D.B. Schutjens, et al.. (2019). The perception of barriers concerning opioid medicines: A survey examining differences between policy makers, healthcare professionals and other stakeholders. Palliative Medicine. 34(4). 493–503. 2 indexed citations
6.
Wolff, Hans, et al.. (2018). Methadone versus torture: The perspective of the European Court of Human Rights. SERVAL (Université de Lausanne). 5 indexed citations
7.
Scholten, Willem, et al.. (2018). Quantifying the Adequacy of Opioid Analgesic Consumption Globally: An Updated Method and Early Findings. American Journal of Public Health. 109(1). 52–57. 30 indexed citations
8.
Scholten, Willem. (2018). Global commission on drug policies misses the mark. 4. 1 indexed citations
9.
Scholten, Willem, Olivier Simon, Icro Maremmani, et al.. (2017). Access to treatment with controlled medicines rationale and recommendations for neutral, precise, and respectful language. Public Health. 153. 147–153. 24 indexed citations
10.
11.
Payne, Sheila, et al.. (2015). A Systematic Content Analysis of Policy Barriers Impeding Access to Opioid Medication in Central and Eastern Europe: Results of ATOME. Journal of Pain and Symptom Management. 51(1). 99–107. 15 indexed citations
12.
Pergolizzi, Joseph V., et al.. (2015). The unique role of transdermal buprenorphine in the global chronic pain epidemic. Acta anaesthesiologica Taiwanica. 53(2). 71–76. 25 indexed citations
13.
Mantel‐Teeuwisse, Aukje K., Saskia Jünger, Willem Scholten, et al.. (2015). Barriers to access to opioid medicines: a review of national legislation and regulations of 11 central and eastern European countries. The Lancet Oncology. 17(1). e13–e22. 26 indexed citations
14.
Scholten, Willem. (2015). Improving access to adequate pain management in Taiwan. Acta anaesthesiologica Taiwanica. 53(2). 62–65. 10 indexed citations
15.
Cleary, James F., Michael Silbermann, Willem Scholten, et al.. (2013). Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in the Middle East: a report from the Global Opioid Policy Initiative (GOPI). Annals of Oncology. 24. xi51–xi59. 55 indexed citations
16.
17.
Danenberg, Esther, et al.. (2013). Modernizing methodology for the WHO assessment of substances for the international drug control conventions. Drug and Alcohol Dependence. 131(3). 175–181. 10 indexed citations
18.
19.
Dijk, Monique van, Maarten Timmers, Kitty G. Snoek, Willem Scholten, & René Albertyn. (2012). How Health Professionals Rate Painfulness of Childhood Injuries and Illnesses: A Survey Study. Journal of Pain & Palliative Care Pharmacotherapy. 26(2). 105–110. 2 indexed citations
20.
Milani, Barbara, et al.. (2011). A First Comparison Between the Consumption of and the Need for Opioid Analgesics at Country, Regional, and Global Levels. Journal of Pain & Palliative Care Pharmacotherapy. 25(1). 6–18. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. R. Rajagopal Breakdown of academic impact, for papers by Martha A. Maurer Breakdown of academic impact, for papers by Roger Hunt Breakdown of academic impact, for papers by Diederik Lohman Breakdown of academic impact, for papers by Andrew W. Roberts Breakdown of academic impact, for papers by Ariadne Rivera‐Aguirre Breakdown of academic impact, for papers by Elizabeth Magnan Breakdown of academic impact, for papers by Andrew Dickman Breakdown of academic impact, for papers by Virginia LeBaron Breakdown of academic impact, for papers by Donald Bourne
Rankless by CCL
2026